Diagnosing and differentiating viral pneumonia and COVID-19 using X-ray images

Abstract

Coronavirus-caused diseases are common worldwide and might worsen both human health and the world economy. Most people may instantly encounter coronavirus in their life and may result in pneumonia. Nowadays, the world is fighting against the new coronavirus: COVID-19. The rate of increase is high, and the world got caught the disease unprepared. In most regions of the world, COVID-19 test is not possible due to the absence of the diagnostic kit, even if the kit exists, its false-negative (giving a negative result for a person infected with COVID-19) rate is high. Also, early detection of COVID-19 is crucial to keep its morbidity and mortality rates low. The symptoms of pneumonia are alike, and COVID-19 is no exception. The chest X-ray is the main reference in diagnosing pneumonia. Thus, the need for radiologists has been increased considerably not only to detect COVID-19 but also to identify other abnormalities it caused. Herein, a transfer learning-based multi-class convolutional neural network model was proposed for the automatic detection of pneumonia and also for differentiating non-COVID-19 pneumonia and COVID-19. The model that inputs chest X-ray images is capable of extracting radiographic patterns on chest X-ray images to turn into valuable information and monitor structural differences in the lungs caused by the diseases. The model was developed by two public datasets: Cohen dataset and Kermany dataset. The model achieves an average training accuracy of 0.9886, an average training recall of 0.9829, and an average training precision of 0.9837. Moreover, the average training false-positive and false-negative rates are 0.0085 and 0.0171, respectively. Conversely, the model’s test set metrics such as average accuracy, average recall, and average precision are 97.78%, 96.67%, and 96.67%, respectively. According to the simulation results, the proposed model is promising, can quickly and accurately classify chest images, and helps doctors as the second reader in their final decision.